Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ESOMEPRAZOLE SODIUM CRS (60 MG)

ESOMEPRAZOLE SODIUM CRS (60 MG)

ND

DISCOVER
ASPARAGINE IMPURITY C CRS (15MG)

ASPARAGINE IMPURITY C CRS (15MG)

ND

DISCOVER
MOXIFLOXACIN FOR SYSTEM SUITABILITY CRS (10 MG)

MOXIFLOXACIN FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
MEBEVERINE HYDROCHLORIDE CRS (10 MG)

MEBEVERINE HYDROCHLORIDE CRS (10 MG)

2753-45-9

DISCOVER
VANCOMYCIN FOR SYSTEM SUITABILITY CRS (15 MG)

VANCOMYCIN FOR SYSTEM SUITABILITY CRS (15 MG)

ND

DISCOVER
MOXIFLOXACIN FOR PEAK IDENTIFICATION B CRS (10 MG)

MOXIFLOXACIN FOR PEAK IDENTIFICATION B CRS (10 MG)

ND

DISCOVER
PROCHLORPERAZINE FOR SYSTEM SUITABILITY CRS (10 MG)

PROCHLORPERAZINE FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
METHYL SALICYLATE CRS (15 MG)

METHYL SALICYLATE CRS (15 MG)

ND

DISCOVER
LEVOFLOXACIN IMPURITY F CRS (15 MG)

LEVOFLOXACIN IMPURITY F CRS (15 MG)

138199-71-0

DISCOVER
LEVOFLOXACIN HEMIHYDRATE CRS (10 MG)

LEVOFLOXACIN HEMIHYDRATE CRS (10 MG)

138199-71-0

DISCOVER
LOPERAMIDE FOR SYSTEM SUITABILITY CRS (15 MG)

LOPERAMIDE FOR SYSTEM SUITABILITY CRS (15 MG)

ND

DISCOVER
CHLORPROTHIXENE FOR SYSTEM SUITABILITY CRS (1 MG)

CHLORPROTHIXENE FOR SYSTEM SUITABILITY CRS (1 MG)

ND

DISCOVER